"The ongoing gutting of the FDA is likely to cause American deaths," said the CEO of one medical device developer.

Anaconda Biomed announced the enrollment and treatment of the first U.S. patient in a clinical trial of its ANA Funnel ...

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...

D-printed implant maker Restor3d announced today that it completed a funding round, bringing in proceeds totaling $38 million ...

Owens & Minor (NYSE:OMI) announced that it upsized and priced an offering of $1 billion in senior secured notes due 2030.

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

FDA CDRH leaders and the entire FDA Office of Media Affairs were reportedly eliminated in the Trump Administration's mass ...

Rhythm Technologies (Nasdaq: IRTC) announced results from two large, real-world analyses demonstrating the benefits of its ...

A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office, reviving a spat between Recor Medical ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Cohen notably served as CEO and a member of the board at Axonics, a company he co-founded in 2013 and took public in 2018. A ...

Bright Uro announced today that it has received FDA 510(k) clearance for its Glean urodynamic analyzer system.